These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 21690470)
1. Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma. Ruden E; Reardon DA; Coan AD; Herndon JE; Hornsby WE; West M; Fels DR; Desjardins A; Vredenburgh JJ; Waner E; Friedman AH; Friedman HS; Peters KB; Jones LW J Clin Oncol; 2011 Jul; 29(21):2918-23. PubMed ID: 21690470 [TBL] [Abstract][Full Text] [Related]
2. Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. Peters KB; West MJ; Hornsby WE; Waner E; Coan AD; McSherry F; Herndon JE; Friedman HS; Desjardins A; Jones LW J Neurooncol; 2014 Dec; 120(3):499-506. PubMed ID: 25115739 [TBL] [Abstract][Full Text] [Related]
3. Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing. Jones LW; Cohen RR; Mabe SK; West MJ; Desjardins A; Vredenburgh JJ; Friedman AH; Reardon DA; Waner E; Friedman HS J Neurooncol; 2009 Aug; 94(1):79-85. PubMed ID: 19212703 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Jones LW; Hornsby WE; Goetzinger A; Forbes LM; Sherrard EL; Quist M; Lane AT; West M; Eves ND; Gradison M; Coan A; Herndon JE; Abernethy AP Lung Cancer; 2012 May; 76(2):248-52. PubMed ID: 22112290 [TBL] [Abstract][Full Text] [Related]
5. Indicators of functional status for primary malignant brain tumour patients. Bussière M; Hopman W; Day A; Pombo AP; Neves T; Espinosa F Can J Neurol Sci; 2005 Feb; 32(1):50-6. PubMed ID: 15825546 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. Carson KA; Grossman SA; Fisher JD; Shaw EG J Clin Oncol; 2007 Jun; 25(18):2601-6. PubMed ID: 17577040 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma. Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187 [TBL] [Abstract][Full Text] [Related]
9. Karnofsky Performance Scale and Neurological Assessment of Neuro-Oncology Scale as Early Predictor in Glioma. Gunawan PY; Islam AA; July J; Patellongi I; Nasrum M; Aninditha T Asian Pac J Cancer Prev; 2020 Nov; 21(11):3387-3392. PubMed ID: 33247700 [TBL] [Abstract][Full Text] [Related]
10. A machine learning-based survival prediction model of high grade glioma by integration of clinical and dose-volume histogram parameters. Chen H; Li C; Zheng L; Lu W; Li Y; Wei Q Cancer Med; 2021 Apr; 10(8):2774-2786. PubMed ID: 33760360 [TBL] [Abstract][Full Text] [Related]
11. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas. Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723 [TBL] [Abstract][Full Text] [Related]
12. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma. Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008 [TBL] [Abstract][Full Text] [Related]
13. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study. Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559 [TBL] [Abstract][Full Text] [Related]
14. Temozolomide in the treatment of recurrent malignant glioma. Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879 [TBL] [Abstract][Full Text] [Related]
15. Clinical prognostic factors in patients with malignant glioma treated with combined modality approach. Jeremic B; Milicic B; Grujicic D; Dagovic A; Aleksandrovic J; Nikolic N Am J Clin Oncol; 2004 Apr; 27(2):195-204. PubMed ID: 15057161 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of post-treatment metabolic tumor volume from Jung TY; Min JJ; Bom HS; Jung S; Kim IY; Lim SH; Kim DY; Kwon SY Neurosurg Rev; 2017 Apr; 40(2):223-229. PubMed ID: 27282449 [TBL] [Abstract][Full Text] [Related]
17. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02. Murray KJ; Nelson DF; Scott C; Fischbach AJ; Porter A; Farnan N; Curran WJ Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):453-9. PubMed ID: 7852106 [TBL] [Abstract][Full Text] [Related]
18. Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. Rajan B; Ross G; Lim CC; Ashley S; Goode D; Traish D; Brada M Eur J Cancer; 1994; 30A(12):1809-15. PubMed ID: 7880611 [TBL] [Abstract][Full Text] [Related]
19. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution. Yang P; Wang Y; Peng X; You G; Zhang W; Yan W; Bao Z; Wang Y; Qiu X; Jiang T J Neurooncol; 2013 Jun; 113(2):259-66. PubMed ID: 23483435 [TBL] [Abstract][Full Text] [Related]
20. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma. Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]